Diagnosis involves the combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align national and international experts and teams to provide accurate diagnoses and treatment plans. Individualised treatment plans for B-cell lymphoma in the blood vessels, typically including drug therapy, rehabilitation interventions, regular follow-up, and more, are needed.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat blood tumour diseases have been significantly improved. Treatment needs to closely monitor efficacy and adverse reactions, adapting timely to changes in conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of intra-vascular B-cell lymphomas.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.